Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ABBOTT LABORATORIES

(ABT)
  Report
Real-time Estimate Cboe BZX  -  01:33 2022-09-29 pm EDT
98.50 USD   -0.22%
05:46aAbt Lawsuit Alert : Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming Deadline
PR
09/28Abbott Hosts Conference Call for Third-Quarter Earnings
PR
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FDA Secures More Baby Formula

06/27/2022 | 07:52am EDT

By Will Feuer


The U.S. Food and Drug Administration said it has secured an additional roughly 1.4 million pounds of baby formula that is expected to be available early next month.

Government officials and formula manufacturers are working to address a nationwide shortage that in recent months has resulted in empty shelves at some stores. Causes for the shortage include pandemic-related supply-chain snarls, a February recall by Abbott Laboratories, as well as the closing of one of its factories.

The agency said it has secured two products, Bellamy's Organic Infant Formula Step 1, which is for new-born children up to six months old, and Bellamy's Organic Follow-On Formula Step 2, which is for those between six months and 12 months old.

The agency said that the U.S. Department of Health and Human Services is evaluating options for getting the product to the U.S. as quickly as possible.


Write to Will Feuer at Will.Feuer@wsj.com


(END) Dow Jones Newswires

06-27-22 0952ET

Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -0.25% 98.52 Delayed Quote.-29.86%
CHINA MENGNIU DAIRY COMPANY LIMITED -3.30% 30.8 Delayed Quote.-27.94%
All news about ABBOTT LABORATORIES
05:46aAbt Lawsuit Alert : Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Act..
PR
09/28Abbott Hosts Conference Call for Third-Quarter Earnings
PR
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
09/21North American Morning Briefing: Caution to Dominate Ahe..
DJ
09/20US FDA Commits to Strengthening Infant Formula Supply
MT
09/17Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technol..
PR
09/17Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technol..
CI
09/16MarketScreener's World Press Review : September 16, ..
MS
09/15Abbott Laboratories : Change in Directors or Principal Officers, Amendments to Articles of..
AQ
09/15Abbott Keeps Quarterly Dividend at $0.47 Per Share, Payable on Nov. 15 to Shareholders ..
MT
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2022 42 510 M - -
Net income 2022 6 680 M - -
Net Debt 2022 6 183 M - -
P/E ratio 2022 26,1x
Yield 2022 1,90%
Capitalization 173 B 173 B -
EV / Sales 2022 4,21x
EV / Sales 2023 4,31x
Nbr of Employees 113 000
Free-Float 87,5%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 98,72 $
Average target price 124,89 $
Spread / Average Target 26,5%
EPS Revisions
Managers and Directors
Robert B. Ford Chairman, President, Chief Executive Officer & COO
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Glenn Fletcher Tilton Independent Director
William A. Osborn Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES-29.86%172 880
MEDTRONIC PLC-20.16%109 775
BECTON, DICKINSON AND COMPANY-6.27%65 700
HOYA CORPORATION-19.61%34 187
DEXCOM, INC.-37.92%32 714
AMERISOURCEBERGEN CORPORATION4.15%28 687